HIV-1
Showing 1 - 25 of >10,000
GeneXpert HIV-1 as The Gold Standard Test for HIV-1 Viral Load
Completed
- HIV
-
Tangerang, West Java, IndonesiaRSU Kabupaten Tangerang
Jul 27, 2023
HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)
Not yet recruiting
- HIV
- HIV Pre-exposure Prophylaxis
- MK-8527
- Placebo to MK-8527
- (no location specified)
Sep 21, 2023
Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction
Not yet recruiting
- Hiv
- +5 more
- differences in CD4 reconstruction
- (no location specified)
Sep 17, 2023
HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))
Not yet recruiting
- HIV-1-infection
- Low-dose STP0404 (Pirmitegravir)
- +3 more
- (no location specified)
May 16, 2023
HIV-1 Reservoir During Cure Interventions Studies (MERCI)
Not yet recruiting
- Hiv
-
Ghent, BelgiumGhent University Hospital
Mar 13, 2023
Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)
Not yet recruiting
- Hiv
- V3G CH848 Pr-NP1 60mcg
- +5 more
-
Birmingham, Alabama
- +5 more
Jun 5, 2023
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Syphilis, HIV Trial in Regina (Reveal Rapid TP (from MedMira))
Recruiting
- Syphilis
- HIV Infections
- Reveal Rapid TP (from MedMira)
-
Regina, Saskatchewan, Canada
- +1 more
May 8, 2023
Healthy Trial (763SIP8/MPLA-5 vaccine)
Not yet recruiting
- Healthy
- 763SIP8/MPLA-5 vaccine
- (no location specified)
Mar 15, 2023
HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam University Medical Centers, location AMC
Jan 31, 2023
HIV-1-infection, Sexually Transmitted Diseases Trial in Madrid (Description)
Completed
- HIV-1-infection
- Sexually Transmitted Diseases
- Description
-
Madrid, SpainHospital Universitario Infanta Leonor
Aug 16, 2023
Analysis of HIV-1 Replication During Antiretroviral Therapy
Enrolling by invitation
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)
Active, not recruiting
- Hiv
- HIV-1-infection
- Lamivudine 300 MG
- Emtricitabine / Tenofovir Disoproxil Pill
-
Buenos Aires, ArgentinaFundacion IDEAA
Jan 2, 2023
HIV Testing, HIV Trial in Edmonton, Toronto, Montréal (OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test)
Active, not recruiting
- HIV Testing
- HIV Infections
- OraQuick ADVANCE® HIV-1/2 Rapid Antibody Test
-
Toronto, Ontario, Canada
- +3 more
Jan 24, 2023
HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)
Not yet recruiting
- HIV-1-infection
- HIV Seropositivity
- Leucapheresis
-
Gent, Oost-Vlaanderen, BelgiumUZ Gent
Jul 25, 2023
Virologic Response in Participants Newly Diagnosed With HIV-1
Completed
- HIV
- Antiretroviral Therapy
-
Lisboa, PortugalChlo - Hosp. Egas Moniz
Jan 17, 2023
HIV-1-infection, Metabolic Syndrome Trial (physical activity)
Not yet recruiting
- HIV-1-infection
- Metabolic Syndrome
- physical activity
- (no location specified)
Jun 6, 2023
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
Observational PIC Destination Cohort
Not yet recruiting
- HIV-1-infection
- (no location specified)
Aug 14, 2023
New Treatment Strategies in Eastern European Region and in
Recruiting
- HIV-1-infection
-
Cologne, Germany
- +3 more
Nov 10, 2023